- $35.98m
- -$53.64m
- $19.89m
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Nodthera Appoints Geoff Mcdonough, M.D., As Independent Board Member
Brief: Xoma Royalty Enters Into Agreement To Acquire Generation Bio
NASDAQ RESUMED AT 05:30 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:55 PM
Generation Bio's Q3 net loss narrows to $5.5 mln
Brief: Generation Bio Announces CEO Transition
U.S. STOCKS ON THE MOVE-Hillenbrand, ImmunityBio, V2X
U.S. STOCKS ON THE MOVE-Lumentum Holdings, ImmunityBio, V2X
U.S. STOCKS ON THE MOVE-Hanesbrands, Bullish, Venture Global
Generation Bio jumps on strategic review, deep job cuts
U.S. RESEARCH ROUNDUP-Apollo, Blackstone, Nvidia
Generation Bio Co reports results for the quarter ended June 30 - Earnings Summary
Generation Bio Co expected to post a loss of $2.85 a share - Earnings Preview
Brief: Generation Bio Q1 EPS USD -0.22
Generation Bio Co reports results for the quarter ended December 31 - Earnings Summary
Brief: Generation Bio Q4 Basic EPS USD -0.32